Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Frailty 12Neoplasms 11Ovarian Neoplasms 5Lymphoma 5Lung Neoplasms 4Breast Neoplasms 4Prostatic Neoplasms 3Multiple Myeloma 3Carcinoma, Non-Small-Cell Lung 3Lymphoma, Large B-Cell, Diffuse 2Hematologic Neoplasms 2Head and Neck Neoplasms 2Fallopian Tube Neoplasms 2Colorectal Neoplasms 2Carcinoma, Hepatocellular 2Urogenital Neoplasms 1Urinary Bladder Neoplasms 1Treatment Adherence and Compliance 1Stomach Neoplasms 1Solid Neoplasm 1Sarcopenia 1Sarcoma 1Recurrence 1Prostate Cancer Cured 1Postoperative Complications 1Pancreatic Neoplasms 1Neoplasms, Plasma Cell 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1

Interventions

Gemcitabine 39Cisplatin 24Oxaliplatin 21Capecitabine 20Fluorouracil 11Leucovorin 9Irinotecan 9130-nm albumin-bound paclitaxel 8durvalumab 6Taxes 5Radiotherapy 5Platinum 4Immunohistochemistry 4Erlotinib Hydrochloride 4Docetaxel 4Carboplatin 4Bevacizumab 4Albumin-Bound Paclitaxel 41,2-diaminocyclohexaneplatinum II citrate 4trifluridine tipiracil drug combination 3Trastuzumab 3Sorafenib 3Observation 3Epirubicin 3Drug Therapy 3tremelimumab 2toripalimab 2regorafenib 2pembrolizumab 2anlotinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Gallbladder Neoplasms × Geriatric Assessment × Clear all
NCT06999512 2025-05-31

HPB70+

Assistance Publique - Hôpitaux de Paris

Phase 2/3 Not yet recruiting
526 enrolled
Gastrointestinal

Gallbladder Neoplasms, Carcinoma, Hepatocellular, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡